INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER

LUCK HJ THOMSSEN C DUBOIS A LISBOA BW UNTCH M KUHNLE H KONECNY G JANICKE F MEERPOHL HG LINDNER C HECKER D DIERGARTEN K

Hj. Luck et al., INTERIM ANALYSIS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 33-36

20

Oncology

Seminars in oncology → ACNP

00937754

23

1

1996

1

33 - 36

ISI

0093-7754(1996)23:1<33:IAOAPS>2.0.ZU;2-2